MedPath

河北瑞森药业有限公司

Ownership
-
Established
2019-02-01
Employees
-
Market Cap
-
Website
http://www.hebeiruisen.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

38

NMPA:38

Drug Approvals

Epalrestat Tablets

Product Name
依帕司他片
Approval Number
国药准字H20253680
Approval Date
Mar 25, 2025
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20253698
Approval Date
Mar 25, 2025
NMPA

Belladonna Sulfamethoxazole and Trimerhoprim Tablets

Product Name
颠茄磺苄啶片
Approval Number
国药准字H13023953
Approval Date
Jul 21, 2020
NMPA

Sulfamethoxazole,Sulfadiazine and Trimethoprim Tablets

Product Name
联磺甲氧苄啶片
Approval Number
国药准字H13020270
Approval Date
Jun 1, 2020
NMPA

Oxytetracycline Tablets

Product Name
土霉素片
Approval Number
国药准字H13020557
Approval Date
Jun 1, 2020
NMPA

Erythromycin Estolate Tablets

Product Name
依托红霉素片
Approval Number
国药准字H13020551
Approval Date
Jun 1, 2020
NMPA

Tetracycline Tablets

Product Name
四环素片
Approval Number
国药准字H13020556
Approval Date
Jun 1, 2020
NMPA

Calcium Lactate,Calcium Gluconate and Calcium Hydrogen Phosphate Chewable Tablets

Product Name
三合钙咀嚼片
Approval Number
国药准字H13023790
Approval Date
Jun 1, 2020
NMPA

Acetylspiramycin Tabelts

Product Name
乙酰螺旋霉素片
Approval Number
国药准字H13023916
Approval Date
Jun 1, 2020
NMPA

vitamin U,Belladonna and Aluminium Capsules

Product Name
维U颠茄铝胶囊
Approval Number
国药准字H13023791
Approval Date
Jun 1, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.